Geneva Capital Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-89,179
Closed -$21.9M 129
2022
Q3
$21.9M Sell
89,179
-1,247
-1% -$337K 0.51% 75
2022
Q2
$22.4M Sell
90,426
-812
-0.9% -$219K 0.52% 77
2022
Q1
$30.2M Sell
91,238
-1,557
-2% -$479K 0.58% 72
2021
Q4
$33.3M Sell
92,795
-3,255
-3% -$1.1M 0.54% 76
2021
Q3
$31.3M Sell
96,050
-4,871
-5% -$1.65M 0.53% 79
2021
Q2
$31.5M Sell
100,921
-3,662
-4% -$1.12M 0.51% 81
2021
Q1
$33.3M Sell
104,583
-5,003
-5% -$1.6M 0.57% 74
2020
Q4
$35.5M Sell
109,586
-12,363
-10% -$3.42M 0.6% 70
2020
Q3
$33.8M Sell
121,949
-6,608
-5% -$1.9M 0.7% 65
2020
Q2
$31.1M Sell
128,557
-2,302
-2% -$462K 0.67% 67
2020
Q1
$19M Buy
+130,859
New +$21.7M 0.54% 76
2014
Q3
$16.5M Sell
666,378
-11,638
-2% -$295K 0.48% 74
2014
Q2
$17M Buy
678,016
+43,170
+7% +$1M 0.42% 76
2014
Q1
$16.5M Buy
634,846
+79,513
+14% +$2.2M 0.39% 75
2013
Q4
$14.8M Buy
555,333
+219,431
+65% +$5.42M 0.34% 85
2013
Q3
$6.4M Buy
+335,902
New +$7.68M 0.15% 102

Other funds holding ABMD